PURPOSE: Family history of colorectal cancer may be a phenotype for numerous genetic mutations which increase colorectal cancer risk and may affect survival after diagnosis. We examined the relationship between self-reported first-degree family history of colorectal cancer and survival. METHODS: We identified female Wisconsin residents ages 20-74 with a new diagnosis of invasive colorectal cancer from two population-based case-control studies; 1,469 women were interviewed. Follow-up averaged 7.9 years. We performed multivariable Cox proportional hazards regressions to calculate adjusted hazard rate ratios [HR] and corresponding 95% confidence intervals [95% CI] for risk of death by family history. RESULTS: Of 1,391 cases with available first-degree family history, 481 were deceased, 268 due to colorectal cancer. In multivariable analyses, cases with any family history (N=262) had a statistically non-significant lower risk of death (HR 0.86, 95% CI 0.62, 1.20) compared to no family history (N=1,129). Cases with two or more affected family members (N=46) showed significantly lower risk of death when compared to women with no family history (HR 0.34, 95% CI 0.13, 0.92). CONCLUSIONS: Although individuals with a colorectal cancer family history are diagnosed with the disease more often than the general population, these data suggest that survival from colorectal cancer may not be worse.
PURPOSE: Family history of colorectal cancer may be a phenotype for numerous genetic mutations which increase colorectal cancer risk and may affect survival after diagnosis. We examined the relationship between self-reported first-degree family history of colorectal cancer and survival. METHODS: We identified female Wisconsin residents ages 20-74 with a new diagnosis of invasive colorectal cancer from two population-based case-control studies; 1,469 women were interviewed. Follow-up averaged 7.9 years. We performed multivariable Cox proportional hazards regressions to calculate adjusted hazard rate ratios [HR] and corresponding 95% confidence intervals [95% CI] for risk of death by family history. RESULTS: Of 1,391 cases with available first-degree family history, 481 were deceased, 268 due to colorectal cancer. In multivariable analyses, cases with any family history (N=262) had a statistically non-significant lower risk of death (HR 0.86, 95% CI 0.62, 1.20) compared to no family history (N=1,129). Cases with two or more affected family members (N=46) showed significantly lower risk of death when compared to women with no family history (HR 0.34, 95% CI 0.13, 0.92). CONCLUSIONS: Although individuals with a colorectal cancer family history are diagnosed with the disease more often than the general population, these data suggest that survival from colorectal cancer may not be worse.
Authors: V Paul Doria-Rose; Polly A Newcomb; Libby M Morimoto; John M Hampton; Amy Trentham-Dietz Journal: Cancer Causes Control Date: 2006-02 Impact factor: 2.506
Authors: Hazel B Nichols; Amy Trentham-Dietz; John M Hampton; Polly A Newcomb Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-05 Impact factor: 4.254
Authors: Adam J Bass; Jeffrey A Meyerhardt; Jennifer A Chan; Edward L Giovannucci; Charles S Fuchs Journal: Cancer Date: 2008-03-15 Impact factor: 6.860
Authors: P Watson; K M Lin; M A Rodriguez-Bigas; T Smyrk; S Lemon; M Shashidharan; B Franklin; B Karr; A Thorson; H T Lynch Journal: Cancer Date: 1998-07-15 Impact factor: 6.860
Authors: Amanda I Phipps; Dennis J Ahnen; Peter T Campbell; Aung Ko Win; Mark A Jenkins; Noralane M Lindor; Robert Gryfe; John D Potter; Polly A Newcomb Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-06-02 Impact factor: 4.254
Authors: E J A Morris; S Penegar; L E Whitehouse; P Quirke; P Finan; D T Bishop; J Wilkinson; R S Houlston Journal: Br J Cancer Date: 2013-03-19 Impact factor: 7.640
Authors: Dawn Q Chong; Barbara L Banbury; Amanda I Phipps; Xinwei Hua; Jonathan Kocarnik; Ulrike Peters; Sonja I Berndt; Wen-Yi Huang; John D Potter; Martha L Slattery; Emily White; Peter T Campbell; Tabitha Harrison; Polly A Newcomb; Andrew T Chan Journal: Cancer Med Date: 2018-03-26 Impact factor: 4.452